Chronic hepatitis C
Virus C genotype predisposes to primary hypothyroidism during interferon- α treatment for chronic hepatitis C
... Chronic hepatitis C diagnosis was investigated through alteration of qALT (ALT of patient/ALT maximum ref- erence values, RV ≤ 1), through the presence of anti- HCV antibody, and was confirmed ...
8
PATIENTS WITH CHRONIC HEPATITIS C AND NORMAL TRANSAMINASES
... with chronic hepatitis C and persistently normal ALT levels are similar to that in patients with elevated ALT ...of hepatitis C can be evaluated independently from baseline ALT ...
5
Assessment of the treatment of chronic hepatitis C in the state of Mato Grosso, central Brazil
... of hepatitis C virus (HCV) infection is funded by the national public health system ...of chronic hepatitis C that are made available by SUS does not, under normal conditions, work as ...
7
Do differences exist between chronic hepatitis C genotypes 2 and 3?
... the hepatitis C virus (HCV) have been identifi ed thus far, and their distribution is well defi ...with chronic hepatitis C infected with genotypes 2 and 3 were studied retrospectively ...
6
Interferon therapy shifts natural killer subsets among Egyptian patients with chronic hepatitis C
... with chronic hepatitis C virus ...with chronic HCV and to analyze the infl uence of interferon therapy on this ...with chronic HCV, in compari- son to 10 control ...
8
Gender influence on treatment of chronic hepatitis C genotype 1
... his cross-sectional study was carried out in a single tertiary care centre (Hepatitis Section, Hospital São Paulo, Brazil) and included consecutive adult naïve patients with biopsy-proven chronic ...
7
Assessment of indicators of vitamin A status in non-cirrhotic chronic hepatitis C patients
... Studies concerning retinol metabolism when there is chronic hepatitis C (CHC) present have gained increasing relevance. Vitamin A exerts antioxidant protection against oxidative stress, which plays ...
6
Chronic Hepatitis C Virus in the State of Piauí, Northeastern Brazil
... The mean age of our patients was about 48 years, similar to what has been described in other studies in Brazil [11,13,17,24,28]. There was no difference between mean ages in patients with genotypes 1 and 3 (48.0 and 47.7 ...
5
Intelligent MONitoring System for antiviral pharmacotherapy in patients with chronic hepatitis C (SiMON-VC)
... with Chronic Hepatitis C on antiviral treatment, prescription-validation-prepara- tion of parenteral nutrition formulations, and traceability of biologics through radiofrequency), and one under deve- ...
21
Portal cd4+ and cd8+ t lymphocyte correlate to intensity of interface hepatitis in chronic hepatitis C
... of chronic hepatitis C is still a matter of ...in hepatitis C progression has not been fully ...with chronic hepatitis ...and hepatitis C ...interface ...
8
Treatment for Chronic Hepatitis C: Drugs and Treatment Response Patterns
... with chronic hepatitis C and presenting detectable serum levels of HCV RNA, together with persistent elevation of aminotransferases, histological evidence of progressive hepatic disease, no severe ...
5
Cost effectiveness of peginterferon alfa-2B combined with ribavirin for the treatment of chronic hepatitis C in Brazil
... The Monte Carlo simulation shows that the treatment with PegIFN alpha 2b, along an entire life time window, is cost- effective in 90.27% and 95.54% of the times, for patients with HCV genotypes 1 and non-1, respectively. ...
9
Chronic hepatitis C: hepatic iron content does not correlate with response to antiviral therapy
... in chronic hepatitis C could not be simply the release of iron from necrotic hepatocytes or the inlammatory-mediated perturbation of iron traficking, when iron would accumulate preferentially in ...
6
Evaluation of prognostic value of cell adhesion molecules in chronic hepatitis C therapy
... in chronic viral hepatitis is the histological staging of the disease, which comprises an invasive procedure and is often not well accepted by ...Thirty chronic hepatitis C patients ...
7
Chronic Hepatitis C: Pathological Anatomy
... of chronic hepatitis ...two chronic hepatitis classification systems be used: the Sociedade Brasileira de Patologia (SBP, Brazilian Society of Pathology) system [13] or the METAVIR system ...
5
In vitro-induced antibody production in chronic hepatitis C virus infection
... Also, no significant correlation was ob- served between viral load and IVIAP levels (P = 0.37). The correlation between the pres- ence of viremia and in vitro antibody pro- duction seems to be clear, as also demon- ...
8
Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection.
... For analysis of anti-gal IgG, pooled serum from 10 healthy controls, 10 patients with stage 1–2 fibrosis (Ishak) and 10 patients Figure 5. Change in LRAGG in response to IFN Treatment in patients with liver fibrosis. (A) ...
11
Tissue and serum immune response in chronic hepatitis C with mild histological lesions
... Several studies have suggested that T-cell immuno- regulatory cytokines play a key role in both HCV viral persistence and in the extent of liver damage. Therefore, while some cytokines may exert a pro-inflammatory ac- ...
8
Longitudinal liver stiffness assessment in patients with chronic hepatitis C undergoing antiviral therapy.
... The improvement in liver stiffness at the end of study was particularly notable for those patients with higher pre-treatment liver stiffness values. As expected, two of the independent baseline predictors of the ...
7